Carson Wealth (CWM LLC)
RLMD icon

Carson Wealth (CWM LLC)’s Relmada Therapeutics RLMD Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-624
Closed -$2K – 4467
2023
Q3 		$2K Hold
624
– – ﹤0.01% 3855
2023
Q2 		$2K Sell
624
-79
-11% -$218 ﹤0.01% 3843
2023
Q1 		$2K Buy
703
+419
+148% +$1.45K ﹤0.01% 3692
2022
Q4 		$1K Buy
284
+265
+1,395% +$2.33K ﹤0.01% 3828
2022
Q3 		$1K Hold
19
– – ﹤0.01% 3740
2022
Q2 		$0 Hold
19
– – ﹤0.01% 4057
2022
Q1 		$1K Hold
19
– – ﹤0.01% 3398
2021
Q4 		$0 Buy
+19
New +$423 ﹤0.01% 3623

Other funds holding RLMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Carson Wealth (CWM LLC)'s RLMD Position: Q4 2023 in Review

Carson Wealth (CWM LLC) sold out of Relmada Therapeutics (RLMD) in Q4 2023, closing a stake of 624 shares — an estimated $2K sold.

Carson Wealth (CWM LLC) first reported a position in RLMD in Q4 2021 and held it in 8 quarters. The position peaked at $2K in Q3 2023. 83 funds tracked by Wall St. Rank hold RLMD as of Q4 2023.

  • Carson Wealth (CWM LLC) reported no remaining Relmada Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 624 Relmada Therapeutics shares in Q4 2023, an estimated $2K.
  • Carson Wealth (CWM LLC) first reported a position in Relmada Therapeutics in Q4 2021 and held it in 8 quarters.
  • Carson Wealth (CWM LLC)'s Relmada Therapeutics position peaked at $2K in Q3 2023.
  • 83 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q4 2023.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2023, filed 1 Feb 2024.